SCHEMBL1851900

SCHEMBL1851900

Nc1nc2ccc(OCCF)nc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 6/20 0.45
PIK3CA P42336 6/20 0.45
PIK3CB P42338 6/20 0.45
PI4KA P42356 6/20 0.45
PI4KB Q9UBF8 6/20 0.45
PIK3CG P48736 5/20 0.45
CYP3A4 P08684 4/20 0.37
TP53 P04637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
PIP5K1C O60331 1/20 0.36
AXL P30530 1/20 0.36
GFER P55789 1/20 0.36
MAPT P10636 2/20 0.35
APP P05067 2/20 0.35
RAB9A P51151 4/20 0.34
NPC1 O15118 3/20 0.34
CYP1A2 P05177 2/20 0.34
SCN4A P35499 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2666814 0.88 PI4KA (0.58) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL30526584 0.83 PIK3CA (0.57) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL30526543 0.81 PIK3CD (0.55) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL184566 0.81 PIK3CD (0.55) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL10233444 0.81 HTR7 (0.46) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL13408569 0.80 PIK3CD (0.40) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL13408571 0.77 MEN1 (0.47) TSHRMAPTRAB9ANPC1
SCHEMBL3512062 0.77 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL10233497 0.76 PIK3CD (0.40) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL10233535 0.76 ALDH1A1 (0.38) PIK3CDPIK3CAPIK3CBPI4KAPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB PIK3CD 4367/4885PIK3CA 4138/4885PIK3CB 3708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.